EPS (Diluted) for DaVita (DVA)
According to DaVita's latest reported financial statements, the company's current diluted EPS (TTM) is $9.07. Diluted earnings per share (EPS) is net income divided by the diluted weighted-average shares outstanding over the period. It expresses profit on a per-share basis — the figure investors use to value an individual share — and accounts for potential dilution from options, RSUs, and convertible securities.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
DVA
Currently viewingEPS (Diluted)Switch metric
TTM (last 4 quarters)
$9.07
YoY change
-11.4%
5Y CAGR
+8.3%
Peak year (2024)
$10.73
Latest annual
$9.51
EPS (Diluted) history chart for DaVita (DVA) from 1994 to 2025
EPS (Diluted) history table for DaVita (DVA) from 1994 to 2025
| Fiscal year | Period ended | Reported | EPS (Diluted) | YoY |
|---|---|---|---|---|
| 2025 | $9.51 | -11.4% | ||
| 2024 | $10.73 | +44.6% | ||
| 2023 | $7.42 | +29.9% | ||
| 2022 | $5.71 | -35.8% | ||
| 2021 | $8.90 | +39.3% | ||
| 2020 | $6.39 | +21.3% | ||
| 2019 | $5.27 | +15.1% | ||
| 2018 | $4.58 | +32.0% | ||
| 2017 | $3.47 | -19.1% | ||
| 2016 | $4.29 | +243.2% | ||
| 2015 | $1.25 | -62.5% | ||
| 2014 | $3.33 | +12.9% | ||
| 2013 | $2.95 | +7.7% | ||
| 2012 | $2.74 | +10.5% | ||
| 2011 | $2.48 | +25.9% | ||
| 2010 | $1.97 | -3.0% | ||
| 2009 | $2.03 | +14.7% | ||
| 2008 | $1.77 | -0.6% | ||
| 2007 | $1.78 | +29.9% | ||
| 2006 | $1.37 | +24.5% | ||
| 2005 | $1.10 | +1.9% | ||
| 2004 | $1.08 | +40.3% | ||
| 2003 | $0.77 | +32.8% | ||
| 2002 | $0.58 | +18.4% | ||
| 2001 | $0.49 | +805.7% | ||
| 2000 | $0.05 | -109.0% | ||
| 1999 | $-0.60 | +3328.6% | ||
| 1998 | $-0.02 | -107.3% | ||
| 1997 | $0.24 | +212.5% | ||
| 1996 | $0.08 | +75.7% | ||
| 1995 | $0.04 | +86.0% | ||
| 1994 | $0.02 | — |
EPS (Diluted) values are taken from DaVita's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
As of the 2025 fiscal year, DaVita (DVA) reported diluted EPS of $9.51 – declined 11.4% year-over-year.
DaVita diluted EPS has recorded the values shown across consecutive periods, with a +8.3% compound annual growth rate over 2020–2025 (5 years).
Between 2024 and 2025, DaVita diluted EPS declined 11.4%, falling from $10.73 to $9.51.
$10.73 stands as the all-time-high annual diluted EPS, posted in 2024, against a low of $-0.60 during 1999.
Among 8 Healthcare peers, DaVita (DVA) ranks 7th; the peer median for diluted EPS is $13.16.
DaVita EPS (Diluted) by Year
DaVita EPS (Diluted) 2025: $9.51
DaVita diluted EPS in 2025 was $9.51, declined 11.4% below 2024.
DaVita EPS (Diluted) 2024: $10.73
DaVita diluted EPS in 2024 was $10.73, surged 44.6% from 2023. This figure represents the highest annual value in the available history.
DaVita EPS (Diluted) 2023: $7.42
DaVita diluted EPS in 2023 was $7.42, grew 29.9% from 2022.
DaVita EPS (Diluted) 2022: $5.71
DaVita diluted EPS in 2022 was $5.71, plunged 35.8% below 2021.
DaVita EPS (Diluted) 2021: $8.90
DaVita diluted EPS in 2021 was $8.90.
See more financial history for DaVita (DVA).
Sector peers — EPS (Diluted)
Companies in the same sector as DaVita, ranked by their latest diluted EPS.
| Company | EPS (Diluted) | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $23.03 | Healthcare |
| Eli Lilly and Company (LLY) | $22.95 | Healthcare |
| Amgen Inc. (AMGN) | $14.23 | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $13.23 | Healthcare |
| AstraZeneca PLC (AZN) | $13.08 | Healthcare |
| Johnson & Johnson (JNJ) | $11.03 | Healthcare |
| Merck & Co., Inc. (MRK) | $7.28 | Healthcare |
| AbbVie Inc. (ABBV) | $2.37 | Healthcare |
Frequently asked questions
What is DaVita's diluted EPS?
- Latest reported diluted EPS for DaVita (DVA) is $9.07 (period ending December 31, 2025).
How has DaVita diluted EPS changed year-over-year?
- DaVita (DVA) diluted EPS changed -11.4% year-over-year on the latest annual filing.
What is the long-term growth rate of DaVita diluted EPS?
- DaVita (DVA) diluted EPS compound annual growth rate is +8.3% over the most recent 5 years available.
When did DaVita diluted EPS hit its highest annual value?
- DaVita diluted EPS reached its highest annual value of $10.73 in 2024.
What was DaVita diluted EPS in 2024?
- DaVita (DVA) diluted EPS in 2024 was $10.73.
What was DaVita diluted EPS in 2025?
- DaVita (DVA) diluted EPS in 2025 was $9.51.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
DVA Overview
Company profile, financial tools, and key metrics
DVA Revenue Counter
Earns $432.62 every second. See per minute, hour, and day.
DVA Earnings Counter
Earns $23.68 per second net profit. See per minute, hour, and day.
DVA Economic Scale
Exceeds Namibia's GDP. Compare with world economies.
DVA What If Invested
What if you had invested $1,000? See historical returns from any date.
DVA How It Makes Money
Discover visual breakdown of $13.64B in revenue — where it comes from and where it goes.
DVA Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
DVA Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
DVA Daily Price Character
Balanced · 50.5% historical win rate (green days). Streaks & record days.
DVA Buybacks
18.33% TTM buyback yield. Shareholder yield & SBC comparison.
DVA Stock Split History
3 splits on record. Dates, ratios, and cumulative multiple.